BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Yang J, Wang J, Kopeček J. Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 2018;12:3658-70. [PMID: 29595951 DOI: 10.1021/acsnano.8b00797] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Koba Y, Nakamoto M, Matsusaki M. Fabrication of a Polymeric Inhibitor of Proximal Metabolic Enzymes in Hypoxia for Synergistic Inhibition of Cancer Cell Proliferation, Survival, and Migration. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c16454] [Reference Citation Analysis]
2 Tommy Gambles M, Li J, Christopher Radford D, Sborov D, Shami P, Yang J, Kopeček J. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo. J Control Release 2022;350:584-99. [PMID: 36037975 DOI: 10.1016/j.jconrel.2022.08.045] [Reference Citation Analysis]
3 Wang Y, Wang J, Zhu F, Wang H, Yi L, Huang K, Zhai Z. Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin's lymphoma patients. Immun Inflamm Dis 2022;10:e616. [PMID: 35478441 DOI: 10.1002/iid3.616] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Wang J, Yang J, Kopeček J. Nanomedicines in B cell-targeting therapies. Acta Biomater 2022;137:1-19. [PMID: 34687954 DOI: 10.1016/j.actbio.2021.10.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Fotouhi P, Sohrabi S, Nosrati N, Vaziri AZ, Khaleghi S, Narmani A, Jafari H, Mohammadnejad J. Surface modified and rituximab functionalized PAMAM G4 nanoparticle for targeted imatinib delivery to leukemia cells: In vitro studies. Process Biochemistry 2021;111:221-9. [DOI: 10.1016/j.procbio.2021.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Seebacher NA, Krchniakova M, Stacy AE, Skoda J, Jansson PJ. Tumour Microenvironment Stress Promotes the Development of Drug Resistance. Antioxidants (Basel) 2021;10:1801. [PMID: 34829672 DOI: 10.3390/antiox10111801] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
7 Gambles MT, Li J, Wang J, Sborov D, Yang J, Kopeček J. Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells. Molecules 2021;26:4658. [PMID: 34361811 DOI: 10.3390/molecules26154658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhou M, Luo C, Zhou Z, Li L, Huang Y. Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade. J Control Release 2021;334:248-62. [PMID: 33915224 DOI: 10.1016/j.jconrel.2021.04.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
9 Li L, Wang J, Radford DC, Kopeček J, Yang J. Combination treatment with immunogenic and anti-PD-L1 polymer-drug conjugates of advanced tumors in a transgenic MMTV-PyMT mouse model of breast cancer. J Control Release 2021;332:652-9. [PMID: 33607175 DOI: 10.1016/j.jconrel.2021.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Yi X, Yan Y, Li L, Li Q, Xiang Y, Huang Y. Sequentially Targeting Cancer‐Associated Fibroblast and Mitochondria Alleviates Tumor Hypoxia and Inhibits Cancer Metastasis by Preventing “Soil” Formation and “Seed” Dissemination. Adv Funct Mater 2021;31:2010283. [DOI: 10.1002/adfm.202010283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Li Y, Li L, Wang J, Radford DC, Gu Z, Kopeček J, Yang J. Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy. J Control Release 2021;329:1129-38. [PMID: 33098912 DOI: 10.1016/j.jconrel.2020.10.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Rütter M, Milošević N, David A. Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs. J Control Release 2021;330:1191-207. [PMID: 33207257 DOI: 10.1016/j.jconrel.2020.11.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bobde Y, Biswas S, Ghosh B. Current trends in the development of HPMA-based block copolymeric nanoparticles for their application in drug delivery. European Polymer Journal 2020;139:110018. [DOI: 10.1016/j.eurpolymj.2020.110018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Di J, Xie F, Xu Y. When liposomes met antibodies: Drug delivery and beyond. Adv Drug Deliv Rev 2020;154-155:151-62. [PMID: 32926944 DOI: 10.1016/j.addr.2020.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
15 Randárová E, Kudláčová J, Etrych T. HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems. Journal of Controlled Release 2020;325:304-22. [DOI: 10.1016/j.jconrel.2020.06.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Lee C, Peddi S, Anderson C, Su H, Cui H, Epstein AL, MacKay JA. Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma. Biomaterials 2020;262:120338. [PMID: 32916604 DOI: 10.1016/j.biomaterials.2020.120338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kopeček J, Yang J. Polymer nanomedicines. Adv Drug Deliv Rev 2020;156:40-64. [PMID: 32735811 DOI: 10.1016/j.addr.2020.07.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
18 Brusini R, Varna M, Couvreur P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv Drug Deliv Rev 2020;157:161-78. [PMID: 32697950 DOI: 10.1016/j.addr.2020.07.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 26.0] [Reference Citation Analysis]
19 Wang J, Li Y, Li L, Yang J, Kopeček J. Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model. Macromol Biosci 2020;20:e1900445. [PMID: 32196951 DOI: 10.1002/mabi.201900445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Li L, Li Y, Yang CH, Radford DC, Wang J, Janát-Amsbury M, Kopeček J, Yang J. Inhibition of Immunosuppressive Tumors by Polymer-Assisted Inductions of Immunogenic Cell Death and Multivalent PD-L1 Crosslinking. Adv Funct Mater 2020;30:1908961. [PMID: 33071706 DOI: 10.1002/adfm.201908961] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
21 Fan F, Piao J, Zhao Y, Jin L, Li M, Wang Y, Yang L. Bioinspired Membrane-Disruptive Macromolecules as Drug-Free Therapeutics. ACS Appl Bio Mater 2020;3:1267-75. [DOI: 10.1021/acsabm.9b01143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Deng J, Walther A. Pathway Complexity in Fuel-Driven DNA Nanostructures with Autonomous Reconfiguration of Multiple Dynamic Steady States. J Am Chem Soc 2020;142:685-9. [DOI: 10.1021/jacs.9b11598] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 20.5] [Reference Citation Analysis]
23 Song L, Chen Y, Ding J, Wu H, Zhang W, Ma M, Zang F, Wang Z, Gu N, Zhang Y. Rituximab conjugated iron oxide nanoparticles for targeted imaging and enhanced treatment against CD20-positive lymphoma. J Mater Chem B 2020;8:895-907. [DOI: 10.1039/c9tb02521a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
24 Xiang Y, Chen L, Li L, Huang Y. Restoration and Enhancement of Immunogenic Cell Death of Cisplatin by Coadministration with Digoxin and Conjugation to HPMA Copolymer. ACS Appl Mater Interfaces 2020;12:1606-16. [PMID: 31804065 DOI: 10.1021/acsami.9b19323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
25 Sun HR, Wang S, Yan SC, Zhang Y, Nelson PJ, Jia HL, Qin L-X and Dong Q-Z. Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment. Front Oncol. 2019;9:1104. [PMID: 31709180 DOI: 10.3389/fonc.2019.01104] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
26 Li L, Wang J, Li Y, Radford DC, Yang J, Kopeček J. Broadening and Enhancing Functions of Antibodies by Self-Assembling Multimerization at Cell Surface. ACS Nano 2019;13:11422-32. [PMID: 31553883 DOI: 10.1021/acsnano.9b04868] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
27 Verhoeven M, Seimbille Y, Dalm SU. Therapeutic Applications of Pretargeting. Pharmaceutics 2019;11:E434. [PMID: 31480515 DOI: 10.3390/pharmaceutics11090434] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
28 Zhou M, Li L, Li L, Lin X, Wang F, Li Q, Huang Y. Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting. Acta Pharm Sin B 2019;9:615-25. [PMID: 31193791 DOI: 10.1016/j.apsb.2018.11.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
29 Wang J, Li L, Yang J, Clair PM, Glenn MJ, Stephens DM, Radford DC, Kosak KM, Deininger MW, Shami PJ, Kopeček J. Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine. Nanomedicine 2019;16:217-25. [PMID: 30639670 DOI: 10.1016/j.nano.2018.12.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
30 Li L, Yang J, Wang J, Kopeček J. Drug-free macromolecular therapeutics exhibit amplified apoptosis in G2/M phase arrested cells. J Drug Target 2019;27:566-72. [PMID: 30198798 DOI: 10.1080/1061186X.2018.1521414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Li L, Yang J, Soodvilai S, Wang J, Opanasopit P, Kopeček J. Drug-free albumin-triggered sensitization of cancer cells to anticancer drugs. J Control Release 2019;293:84-93. [PMID: 30465822 DOI: 10.1016/j.jconrel.2018.11.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
32 Yang J, Li L, Kopeček J. Biorecognition: A key to drug-free macromolecular therapeutics. Biomaterials 2019;190-191:11-23. [PMID: 30391799 DOI: 10.1016/j.biomaterials.2018.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]